This episode is a Q&A on longevity investing with Sergey Young from Longevity Vision Fund and Neil Littman from Bioverge.
Sergey Young is a longevity investor and visionary with a mission to extend the healthy lifespans of 1 billion people. He is the founder of the $100M Longevity Vision Fund—one of the few funds specializing exclusively in longevity and helping to accelerate longevity breakthroughs.
Neil J. Littman is the Founder, CEO, and General Partner at Bioverge, an impact investment platform exclusively dedicated to investing in early-stage, cutting-edge healthcare companies.
Sergey speaks about his book, Growing Young, which covers different technologies and discoveries on the near horizon. He believes that it is unlikely that a single intervention will create the change necessary, so he is building a portfolio of different technologies to target aging.
Neil Littman discusses his experience at the California Institute of Regenerative Medicine where he saw a girl cured of combined immunodeficiency disorder using gene therapy.
Session Summary: Sergey Young, Longevity Vision Fund | Neil Littman, Bioverge | Longevity Investing - Foresight Institute
The Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.
Allison Duettmann is the president and CEO of Foresight Institute. She directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, Fellowships, Prizes, and Tech Trees, and shares this work with the public. She founded Existentialhope.com, co-edited Superintelligence: Coordination & Strategy, co-authored Gaming the Future, and co-initiated The Longevity Prize.
Apply to Foresight’s virtual salons and in person workshops here!
We are entirely funded by your donations. If you enjoy what we do please consider donating through our donation page.
Visit our website for more content, or join us here:
","author_name":"Foresight Institute"}